Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Oct 8, 2010


Caprotec Bioanalytics last week launched new caproKits for C2 CAMP, dasatinib, and biotin capping.

The launch of the three kits brings the total of commercially available caproKits to 10 and expands the company's portfolio into the areas of signal transduction, epigenetics, and proteases. CaproKits are based on Caprotec's Capture Compound Mass Spectrometry technology, which allows the isolation and identification of defined protein classes, reducing proteome complexity to enable easier analysis of target molecules, according to the company.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.